|
Clinical Decision Support (CDS) Federal Collaboratory and Inventory of Federal Clinical Decision Support Activities
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, HRSA, IHS, OS
|
NLM, CC
|
A federal community of interest focused on clinical decision support, and a compilation of project summaries describing CDS activities that are either funded by the US Federal government, or that are being executed by agencies of the government. The term Clinical Decision Support (CDS) describes a variety of tools and technologies that are used within electronic clinical information systems to improve the quality, safety, efficiency and effectiveness of patient care. CDS provides clinicians, staff, patients, and other key decision makers with knowledge and person-specific information, intelligently filtered at appropriate times, to enhance health and health care. CDS encompasses computerized alerts and reminders, clinical guidelines, order sets, order entry feedback, patient data reports and dashboards, documentation templates, diagnostic support, and the presentation of contextually relevant reference information within clinical information systems. NLM has submitted to the Collaboratory and Inventory summaries of NLM projects involving Clinical Decision Support.
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
This Working Group discusses a range of issues relevant to the development of antiviral drugs for the treatment of influenza.
|
|
Clinical Islet Transplantation Consortium
|
Research Initiative
|
CMS, FDA
|
NIDDK, NIAID
|
"The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in people with type 1 diabetes.
Studies conducted by the CIT Consortium will focus on improving the safety and long-term success of methods for transplanting islets, the insulin-producing cells of the pancreas, in people whose own islets have been destroyed by the autoimmune process that characterizes type 1 diabetes. One clinical trial, in particular, is studying the efficacy of islet transplantation after kidney transplantation. Participants may include Medicare beneficiaries. This study was mandated in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. "
|
|
Clinical studies in fecal incontinence committee
|
Other
|
CDC
|
NICHD
|
The purpose of this committee was to plan a meeting to present the research world with information on the state of fecal incontinence research and generate discussion about how to move forward research that will improve treatment and outcomes in people with fecal incontinence.
|
|
Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, OS
|
NLM
|
NLM is collaborating with OS and HHS Office of the National Coordinator for Health Information Technology (ONC) on developing and disseminating regulatory language related to health information technology, meaningful use, and standards and certification criteria related to electronic health records and messaging. Collaboration includes serving as members of the Vocabulary Task Force and Clinical Operations Workgroup of the Health IT Standards Committee. The HIT Standards Committee is a Federal advisory committee that was created by the Health Information Technology for Economic and Clinical Health (HITECH) Act to provide input to HHS on the policies and technologies needed to improve health and care.
|
|
Clinical Vocabulary and Standards Development for Quality Measures
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, OS
|
NLM
|
We are developing and assessing the feasibility of standards-based quality measures that will utilize EMR data. In 2012, NLM developed a system for validating value sets used in Meaningful Use Stage 2 clinical quality measures.
|
|
ClinicalTrials.gov
|
Resource Development
|
FDA
|
NLM, CC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD/OSP
|
ClinicalTrials.gov is an NLM-operated database of summary protocol and results information from publicly and privately funded clinical research. As of February 2013, the database included over 141,000 studies conducted in 182 countries with over 8,200 summary results. NLM originally collaborated with FDA on implementing Section 113 of the Food and Drug Administration Modernization Act. It is currently collaborating with FDA and other parts of NIH to implement the statutory requirements of Section 801 of the Food and Drug Administration Amendments Act of 2007.
|
|
CMS-NIH Collaborations on CMS Innovation Center
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
OD/OSP, CC, CSR, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
The Innovation Center aims to test innovative payment and service delivery models to reduce program expenditures under Medicare, Medicaid, and CHIP, while preserving or enhancing the quality of care furnished. CMS and NIH have been discussing potential collaborations including:
• Development of an RFA on “Promotion of Clinically Integrated Randomized Controlled Trials (in process)
• Implementation of NIH-supported Research Findings: NIH has proposed high impact research results that could be rapidly and successfully implemented on a larger scale. Initiatives under active consideration include implementation of research findings in the arena of early intervention in schizophrenia episodes and post-acute stroke care.
|
|
CMS-NIH Data Access Committee
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
OD/OSP, CC, CSR, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
Observational studies based, in part, on available CMS data could generate important knowledge and policy relevant findings. NIH and CMS established a Data Access Committee to identify and pursue short and long term priorities. The group convened one formal meeting last year, but touches base informally via email and phone. Current initiatives include:
• Exploration of an agreement wherein NIH directly purchases blanket access to CMS data from CMS, instead of paying grantees to access these data individually(which incurs high indirect cost rates for NIH).
• Quarterly meetings of the CMS-NIH Data Access Committee discuss data policy and access issues. Future meetings will include presentations by NIH-funded investigators and in-house CMS data analyses.
|
|
CMS-NIH Senior Leadership Forum
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
OD/OSP, NCI, NHLBI, NIA, NIDDK, NINDS
|
A “CMS-NIH Senior Leadership Forum” comprised of NIH Director Francis Collins, CMS Acting Administrator Marilyn Tavenner, and Senior Staff from both agencies, convenes quarterly. Topics include:
• NIH-supported research findings of interest to CMS in high impact conditions such as diabetes, schizophrenia, post-acute stroke care, prevention of pre-term birth, tobacco cessation, etc.
• Enhancing investigator access to CMS data through the use of Data Enclaves.
• Development of common data elements (CDEs) to enhance the conduct of clinical research.
• Collaborative development of an RFA, “Promotion of Clinically-Integrated Randomized Controlled Trials”, to be issued and funded by NIH.
|